Francesca Gany, MD, MS, Chief of the Immigrant Health and Cancer Disparities Service, and Tim Ahles, PhD, Director of the Neurocognitive Research Laboratory, both of Memorial Sloan Kettering Cancer Center (MSK), along with Gilda Barabino, PhD, and Karen Hubbard, PhD, of the City College of New York (CCNY), were awarded grant funding from the National Cancer Institute (NCI) as part of the CCNY-MSK partnership. They will receive almost $15 million over the next 5 years in support of the partnership’s goal to reduce cancer disparities through research, training, and community outreach.
Francesca Gany, MD, MS
Tim Ahles, PhD
Gilda Barabino, PhD
Karen Hubbard, PhD
More About the Partnership and Researchers
Established in June 2002, the CCNY-MSK partnership aims to support basic and applied cancer research initiated by CCNY investigators; support research initiated by MSK investigators on health disparities and cancer burdens in minority populations; implement joint education and training opportunities to attract minority students at all stages of their careers; and combine the resources of both institutions to develop and evaluate health outreach initiatives in medically underserved communities.
Specializing in immigrant health and cancer disparities, Dr. Gany works with MSK to serve immigrants, minority community members, and the medically underserved within the health-care system and to eliminate the health disparities found therein. Before joining MSK, Dr. Gany earned her medical degree from the Mount Sinai School of Medicine and completed a fellowship and residency at the NYU Medical Center, where she founded and served as Director of the Center for Immigrant Health.
As a psychologist at MSK, Dr. Ahles’ clinical expertise is in behavioral medicine and the neurocognitive side effects of cancer treatment. Dr. Ahles earned his PhD in clinical psychology at the State University of New York at Albany and completed residencies at the University of Mississippi Medical Center and the Veterans Administration Medical Center in Jackson, Mississippi.
More About CCNY Researchers
Dr. Barabino is the Daniel and Frances Berg Professor and Dean of Biomedical Engineering at CCNY’s Grove School of Engineering. Her lab focuses on the characterization and quantification of mechanical and biochemical cues that influence tissue growth and disease progression. The goal of this research is to develop novel therapies for patients with sickle cell disease and other illnesses associated with damaged cartilage and bone. In addition, Dr. Barabino is noted for her research in race/ethnicity and gender in science and engineering.
Also employed at CCNY, Dr. Hubbard is Professor of Biology and the Director of the CCNY-MSK partnership program. Trained as a molecular biologist with a PhD in biology from the Illinois Institute of technology in Chicago, her research focuses on RNA metabolism during aging and its relationship with apoptosis.
